We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A third of financial institutions are accelerating their AI and machine learning (ML) adoption for anti-money laundering (AML) technology in response to COVID-19.
bioMérieux Inc., a world leader in in vitro diagnostic solutions for infectious disease, has partnered with global analytics leader SAS to help combat antimicrobial resistance.